Reza Vaezeafshar, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5800 Hollis St, Emeryville, CA 94608 Phone: 510-465-0941 |
Dr. Christine Miran Kim, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5800 Hollis St Fl 4, Emeryville, CA 94608 Phone: 510-806-2100 Fax: 510-806-2558 |
News Archive
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
Exercise has proven health benefits, but easing hot flashes isn't one of them. After participating in a 12-week aerobic exercise program, sedentary women with frequent hot flashes had no fewer or less bothersome hot flashes than a control group.
Children with clinical signs of tuberculosis but with a negative tuberculin skin test result should not have treatment delayed, suggest study findings showing that false-negatives are common and associated with high mortality.
While prevention methods appear to be helping to lower hospital infection rates from MRSA, a deadly antibiotic-resistant bacterium, a new superbug is on the rise, according to research from the Duke Infection Control Outreach Network.
› Verified 1 days ago